Tuberculosis experts pin hopes of controlling disease on 12 vaccines in developmentBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e6981 (Published 16 October 2012) Cite this as: BMJ 2012;345:e6981
- Geoff Watts
The advent of more effective vaccines against tuberculosis is an increasingly realistic possibility, say public health experts with an interest in the illness. Tuberculosis is currently the world’s second deadliest infection, with 8.8 million new cases in 2010.
“In the last decade we’ve gone from having no vaccines in development to now having 12 different candidates at various stages in the clinic and in human trials,” said Ann Ginsberg, vice president of scientific affairs for Aeras, a foundation devoted to the development of vaccines against tuberculosis.
Increasingly concerned over the rise of drug resistant tuberculosis, she and others in the field have long insisted that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial